HomeServicesDoctorsAbout UsContact UsNews & UpdatesVideosGalleryBlogCall Us For An Appointment
Mobile No. - +91 9138111625|Landline No. - +91 130 298 4289
About UsContact UsNews & UpdatesVideosGalleryBlogs
Dr. Aashish Gambhir
Dr. Aashish Gambhir

MBBS, DRM (Gold Medallist), DNB (Nuclear Medicine)
AERB certified RSO II and RSO III (NM Therapy)
Director Nuclear Medicine, PET CT and Nuclear Theranostics
Andromeda Cancer Hospital

Brief Profile

Dr. Aashish Gambhir is an experienced Nuclear Medicine Physician with over 13 years of experience in the field. He is trained extensively and actively participating in Multiple Molecular Imaging modalities including Gamma camera scintigraphy/Conventional Nuclear Medicine, PET-CT imaging, PET-MRI imaging, Radionuclide therapy & Nuclear Theranostics / Nuclear oncology and is also a Practicing Thyroidologist.
He holds an MBBS from prestigeous Maulana Azad Medical College (MAMC, New Delhi) / LNJP Hospital and completed his DRM (Diploma in Radiaiton Medicine) from Institute of Nuclear Medicine and Allied Sciences, INMAS, New Delhi follwed by DNB in Nuclear Medicine from Apollo Hospitals, Chennai. Additionally, he is a AERB certified Radiation Safety Officer RSO level II and III (Nuclear Medicine Therapy). He is one of the very few NM Physicians in the country with training and experience with PET MRI based molecular imaging.
Prior to joining Andromeda Cancer Hospital, he has served as Consultant, Nuclear Medicine at Rajiv Gandhi Cancer Institute, Delhi and as SR-cum-Research cordinator in PET MRI suite, Indraprastha Apollo Hospitals, New Delhi. He has also served as Head of Nuclear Medicine Department at Yashoda hospitals, Ghaziabad in addition to consultant roles at HOD, Faridabad, Ganesh Diagnostics, Rohini and Narula Diagnostics, Rohtak.
Dr. Aashish Gambhir specializes in day-to-day molecular imaging needs of oncological and non-oncological practice with keen interest in using PET CT / PET MRI with newer tracers such as FAPI, Tivehexin, exendin etc in addition to advancements in Nuclear Theranostics / Therapies for various cancers such as Radio-iodine for thyroid cancer, PRRT for NET, PSMA therapy / PRLT for prostate cancer and FAPI therapy for various malignancies.
He works meticulously with multidisciplinary teams to deliver personalized care and stays abreast of the latest advances in cancer diagnosis and treatment.
He is also a exexcutive committe member of Northern chapter of Society of Nuclear Medicine, India and is actively engaged in research, education, and awareness initiatives focused on breast cancer.

Education

  • MBBS: 2007–2012 Maulana Azad Medical College (MAMC), Lok Nayak Hospital and GB Pant Hospital, New Delhi- 11002
  • Dip. In Radiation Medicine (DRM), 2013-2015 Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO, Timarpur, New Delhi-110054
  • DNB Nuclear medicine 2016-2018 Department of Nuclear medicine and PET-CT, Apollo Hospitals, 21 Greams Lane, Off Greams Road, Chennai, Tamil Nadu-600006
Work Experience

  • March 2025 onwards: Director and Head, Nuclear Medicine, PET CT and Nuclear Theranostics, Andromeda Cancer Hospital
  • 2024 – 2025: Consultant, Nuclear Medicine, Rajiv Gandhi Cancer Institute & Research Centre, Rohini, Delhi
  • 2023 – 2024: Consultant, Ganesh Diagnostics and Imaging Centre, Department of Nuclear Medicine, PET-CT and Theranostics, Rohini Delhi
  • 2021 - 2023: Consultant, Nuclear Medicine Division, Narula Diagnostics, Department of Nuclear Medicine, PET-CT and Theranostics, Rohtak, Haryana
  • 2019 - 2021: Consultant and Head, Department of Nuclear Medicine and PET-CT, Yashoda Hospital and Research Centre, Department of Nuclear Medicine and PET-CT, Ghaziabad, UP
  • 2018 - 2019: Consultant and Head, Department of Nuclear Medicine and PET-CT, House of Diagnostics (HOD), Faridabad, Haryana,
  • 2016 – 2018: Senior Resident (DNB - academic), Secondary DNB resident, Department of Nuclear medicine and PET-CT, Apollo Hospitals, 21 Greams Lane, Off Greams Road, Chennai, Tamil Nadu
  • 2015 - 2016: Senior Resident-cum-Research coordinator for PET/MRI, in PET SUITE, Department of Molecular Imaging and Nuclear Medicine, Indraprastha Apollo Hospital, Mathura Road, New Delhi

Memberships
•⦁ Life Member
⦁ Associations of Nuclear Medicine Physcians of India (ANMPI)
⦁ Society of Nuclear Medicine of India (SNMI)
Special skills/Training/Services and Treatment offered

Dr. Aashish is highly proficient in the following:

  • Manage a functioning department of nuclear medicine with a PET-MRI, PET-CT, SPECT-CT/Gamma camera, Thyroid Probe and high (and low) dose therapy isolation ward
  • Confidently manage, acquire and report both conventional gamma camera imaging including planar, SPECT and SPECT/CT and PET/CTor integrated PET/MRI encompassing scans spanning General nuclear medicine, nuclear oncology, nuclear cardiology, nuclear neuro-psychiatry, infection imaging and therapeutic nuclear medicine.

  • Tracers handled/worked on:

     

    • All conventional Gamma Camera Based Tracers: 99mTc labeled-DTPA, DMSA, MDP, HIDA, Sulfur Colloid, Pertechnetate, SestaMIBI, 99mTc-HYNICTOC, TRODAT, Ubiquicidin, I-131 NaI, I-131-Mibg. etc.

       

    • PET tracers: 18F–NaF, 18F-FDG, 18F-PSMA, 18F-Choline, 18F-FET, 18F-FES, 18F-DOPA, 11C-Methionine, 11C-Choline, 18O-Labelled H20, 68Ga HBED-CC PSMA-11, 68Ga-DOTANOC, 68Ga-DOTA-Exendin-4, 68Ga-FAPI, 68Ga-Trivehexin.

       

    • Therapeutic: I-131 NaI, I-131-mIBG, 177Lu-DOTATATE, 177Lu-PSMA-617, 90Y-TARE/SIRT with SIRspheres.

  • PET MRI based molecular imaging
  • Animal PET and SPECT tracers and preclinical research done at INMAS.
  • Radionuclide therapies (PSMA therapy, PRRT - DOTANOC therapy, FAPI therapy, MIBG therapy) and Recent advances
  • Thyroidology dealing with benign and malignant thryoid disorders.
  • Multimodality and Multidisciplinary cancer management and Tumor Board.
  • PET guided interventions including PET guided biopsy and biopsy planning, TARE planning etc.

Publications and Research

Publications:

  1. Mehra, Lalita, Kumar, Amit, Gambhir, Aashish, Dutta, Mita, Bhatnagar, Aseem, Mittal, Gaurav, & Hasija, Yasha (2013). Experimental study on role of alpha ketoglutarate as hepato protective agent: A 99mTc sulphur colloid hepatobiliary imaging in CCl4 fibrotic rat model. Indian Journal of Nuclear Medicine, 28(5,suppl), S18.
  2. Jaimini, A., Dsouza, M.M, Gambhir, A., James, V.M., Sharma, R. and Mondal, A., 2014. Post radiation tumor recurrence comparative evaluation in gliomas on MR and 11C-Methionine PET/CT.
  3. Gambhir A, James VM, Kumar A, Jaimini A, Mondal A. Bilateral Crossed "Unfused" Renal Ectopia. Clin Nucl Med. 2015 Oct;40(10):805-7. doi: 10.1097/RLU.0000000000000896.
  4. Jena A, Taneja S, Gambhir A, Mishra AK, Verma SM, Hazari PP, Negi P, Jadhav GKR, Sogani SK. NIMG-36: Comprehensive Evaluation Of Glioma Recurrence With Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine (18F-FET) Positron Emission Tomography Magnetic Resonance Imaging (PET MRI). Neuro Oncol. 2015 Nov;17(Suppl 5):v161–2. doi: 10.1093/neuonc/nov225.36. Epub 2015 Nov 9. PMCID: PMC4639059.
  5. Jena A, Taneja S, Gambhir A, Mishra AK, Dʼsouza MM, Verma SM, et al. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI. Clin Nucl Med. 2016 May;41(5):e228-36. doi: 10.1097/RLU.0000000000001152.
  6. Jena A, Taneja S, Gambhir A, et al. Single session 18F-FET simultaneous PET/MRI including uptake kinetics in distinguishing glioma recurrence and radiation necrosis. Journal of Nuclear Medicine. 2016;57(supplement 2):31.
  7. Sogani SK, Jena A, Taneja S, Gambhir A, Mishra AK, D'Souza MM, Verma SM, Hazari PP, Negi P, Jadhav GK. Potential for differentiation of glioma recurrence from radionecrosis using integrated 18F-fluoroethyl-L-tyrosine (FET) positron emission tomography/magnetic resonance imaging: A prospective evaluation. Neurol India. 2017 Mar-Apr;65(2):293-301. doi: 10.4103/neuroindia.NI_101_16.
  8. Jena A, Renjen PN, Taneja S, Gambhir A, Negi P. Integrated (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging ((18)F-FDG PET/MRI), a multimodality approach for comprehensive evaluation of dementia patients: A pictorial essay. Indian J Radiol Imaging. 2015 Oct-Dec;25(4):342-52. doi: 10.4103/0971-3026.169449.
  9. Gambhir, Aashish, Jena, Amarnath, Taneja, Sangeeta, & Negi, Pradeep (2015). Simultaneous positron emission tomography-magnetic resonance imaging with Gallium 68 prostate-specific membrane antigen: next footstep in imaging of recurrent prostate cancer-initial results and preliminary experience. Indian Journal of Nuclear Medicine, 30(5,suppl), 15-16.
  10. Jena A, Taneja S, Gambhir A, Renjen PN. Integrated PET/MRI imaging of semantic dementia. Neurol India. 2016 Jul-Aug;64(4):826-7. doi: 10.4103/0028-3886.185365.
  11. Sogani SK, Jena A, Taneja S, Gambhir A, Mishra AK, D'Souza MM, Verma SM, Hazari PP, Negi P, Jadhav GK. Potential for differentiation of glioma recurrence from radionecrosis using integrated 18F-fluoroethyl-L-tyrosine (FET) positron emission tomography/magnetic resonance imaging: A prospective evaluation. Neurol India. 2017 Mar-Apr;65(2):293-301. doi: 10.4103/neuroindia.NI_101_16. PMID: 28290392.
  12. Gambhir, Aashish, Muthukrishnan, Indirani, Amalachandran, Jaykanth, Kalal, Shilpa, Jain, Avani, Khare, Abhishek, & Simon, Shelley (2016). 13-Cis-retinoic acid therapy in combination with recombinant human thyrotropin for treatment of dedifferentiated thyroid cancer: a pilot study. World Journal of Nuclear Medicine (Online), 15(suppl1), S28-S29.
  13. Jain AS, Simon S, Muthukrishnan I, Gambhir A, Patil S. Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT.ClinNucl Med. 2017 Apr;42(4):315-318. doi: 10.1097/RLU.0000000000001574.
  14. Gambhir A, Elangovan I, Simon S, Jain A. Postrenal Transplant Allograft "Page Kidney" Identified and Salvaged using 99mTc-diethylenetriaminepentaacetic acid Renogram and Single-photon Emission-computed Tomography.Indian journal of nuclear medicine. 2018 Apr-Jun;33(2):161-164. doi: 10.4103/ijnm.IJNM_155_17.
  15. Gambhir A, Jain A, Elangovan I, Simon S.Baseline Pancreatic Beta cell imaging post pancreatic transplantation using whole body 68Ga-DOTAExendin-4 PET/CT: A spectrum of two cases of diabetes mellitus.ClinNucl Med. 2019 Apr;44(4):292-294. doi: 10.1097/RLU.0000000000002461.
  16. Gambhir A. Pancreatic transplant associated tuberculosis diagnosed and followed up on whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Transplant 2019;13:46-9.
  17. Gambhir A. Utility of MDP Bone Scan in Following Up Patients with Sapho Syndrome. Indian J Nucl Med. 2020 Apr-Jun;35(2):187-188. doi: 10.4103/ijnm.IJNM_199_19. Epub 2020 Mar 12. PMID: 32351283; PMCID: PMC7182324.
  18. Gupta A, Gambhir A. PET CT Brain for the Differential Diagnosis of Dementia -Indian Case Reports. The Open Neurology Journal. 2020 Sep; 14: 68-73. DOI: 10.2174/1874205X02014010068.
  19. Section 6: Awards, Achievements and Initiatives
  20. Brig. S.K Majumdar Memorial Trust DRM award for best outgoing DRM student 2015 at Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi.
  21. Dr N.RamdasThyroidology Award 2014-2015at the 46th annual conference of Society of Nuclear Medicine-India (SNMI), Kolkata for oral presentation titled “The role of C-11 methionine PET/CT in Primary Hyperparathyroidism.”
  22. Best poster award 2014-2015 at the 46th annual conference of Society of Nuclear Medicine-India (SNMI), Kolkata for poster titled “Bilateral crossed renal ectopia “unfused”-a rare entity assessed onTc 99m-DTPA scan”
  23. Actively participation in various cancer awareness activities and awareness talks etc.
  24. Many National and International presentations, participated in many panel discussions, webinars and DNB teaching programmes.